Microdose therapy

Details for Australian Patent Application No. 2002311264 (hide)

Owner Cellegy Pharmaceuticals, Inc

Inventors Heaton, Jeremy P.W; Adams, Michael A; Banting, James D

Agent Davies Collison Cave

Pub. Number AU-B-2002311264

Parent 80961

Filing date 22 November 2002

Wipo publication date 20 March 2003

Acceptance publication date 15 September 2005

International Classifications

A61K 031/00

Event Publications

19 December 2002 Complete Application Filed

20 March 2003 Application Open to Public Inspection

  Published as AU-B-2002311264

8 September 2005 Assignment before Grant

  Queen's University at Kingston The application has been assigned to Cellegy Pharmaceuticals, Inc

15 September 2005 Application Accepted

  Published as AU-B-2002311264

19 January 2006 Standard Patent Sealed

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002311265-Hydrocracking process to maximize diesel with improved aromatic saturation

2002311263-USE OF CINNAMIC ACID GROUPS CONTAINING ACETAL POLYMERS FOR RADIATION-SENSITIVE COMPOSITIONS AND LITHOGRAPHIC PRINTING PLATES